000048289 000__ 01501cam\a22004215i\4500
000048289 001__ 48289
000048289 003__ SzGeWIPO
000048289 005__ 20240708150401.0
000048289 006__ m\\\\eo\\d\\\\\\\\
000048289 007__ cr bn |||m|||a
000048289 008__ 230613s2023    nyu|||||o|||||000|0 eng|d
000048289 035__ $$a(OCoLC)1393694666
000048289 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO
000048289 041__ $$aeng
000048289 24500 $$aTeva v Novartis: spinning around.
000048289 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2023
000048289 300__ $$a1 online resource
000048289 336__ $$atext$$2rdacontent
000048289 337__ $$acomputer$$2rdamedia
000048289 338__ $$aonline resource$$bcr$$2rdacarrier
000048289 4901_ $$aEuropean Intellectual Property Review,$$x0142-0461 ;$$vVolume 45, Issue 5
000048289 542__ $$fhttps://1.next.westlaw.com/Copyright
000048289 588__ $$aCrossref
000048289 590__ $$aPublished online: 2023
000048289 650_0 $$aIntellectual property.
000048289 650_0 $$aConflict of laws.
000048289 650_0 $$aPharmaceuticals.
000048289 650_0 $$aPatent law$$zEuropean Union.
000048289 650_0 $$aPatents.
000048289 650_0 $$aEconomic development projects$$xDirectories.
000048289 7001_ $$aJacob, Reuben,$$eauthor.
000048289 7001_ $$aStrath, Janet,$$eauthor.
000048289 7731_ $$tEuropean Intellectual Property Review
000048289 7731_ $$wEIPR
000048289 830_0 $$aEuropean Intellectual Property Review,$$x0142-0461 ;$$vE.I.P.R. 2023, 45(5), 292-295
000048289 85641 $$uhttps://www.westlaw.com/Document/I4DD53620DD0F11ED81FEEC400A48B194/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000048289 904__ $$aJournal article
000048289 980__ $$aEIPR